Vetter, one of the global leaders in prefilled drug-delivery systems, announced the official opening of a new branch office in South Korea on Friday. The new office in Songdo located within the biologics cluster referred to as a 'sweet spot' by the industry as it houses numerous prominent biopharmaceutical companies and service providers.
Strengthening its global footprint in the Asia Pacific (APAC) region has been going on for Vetter. The company established its APAC hub in Singapore in 2014, and subsequently formed a Japanese subsidiary by opening an office in Tokyo in 2015. Although the pharmaceutical service provider had already been active in the South Korean market for years, the establishment of its own local branch office underlines the company's commitment to the Asia Pacific market in South Korea.
With the new footprint, Vetter is likely to be positioned well to support its existing South Korean business as well as that of new local and global customers, helping them to meet stringent development, manufacturing and packaging requirements of their inject able drugs.
"This new office will allow us to serve both local and global companies with South Korean market interests," said Vetter Managing Director Peter Soelkner. "We will certainly serve as an additional base and contribution for Vetter's future global organic growth, vetter added.
